功能获得性增强子优化 CAR-NK 细胞抗肿瘤免疫治疗
Gain-of-function enhancers optimize CAR-NK cell-based anti-cancer immunotherapy.
50.8分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Gain-of-function enhancers optimize CAR-NK cell-based anti-cancer immunotherapy.
An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor Responses.
Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian Cancer.
CAR-NK cell therapy for overcoming antigen heterogeneity and immunosuppressive tumor microenvironments.
CliCAR: A non-genetic CAR engineering strategy to empower NK cells for targeted cancer immunotherapy.
Integration of ζ-deficient CARs into the CD3-zeta gene conveys potent cytotoxicity in T and NK cells.
共 6 条
MEMBER ACCOUNT
登录成功会直接打开下一页。